American Heart Journal
Volume 138, Issue 3 , Pages 400-402 , September 1999

Long-term nitrate use in chronic coronary artery disease: Need for a randomized controlled trial

References 

  1. Abrams J. Hemodynamic effects of nitroglycerin and long-acting nitrates. Am Heart J. 1985;10:216–224
  2. Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol. 1992;70:30B–42B
  3. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, et al.  Mechanism of smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739–749
  4. Imhof PR, Ott B, Frankhuaser P, Chu LC, Hodler J. Difference in nitroglycerin dose response in the venous and arterial beds. Eur J Clin Pharmacol. 1980;18:455–460
  5. McGregor M. Pathogenesis of angina pectoris and role of nitrates in relief of myocardial ischemia. Am J Med. 1983;74(suppl):21–27
  6. Held PH, Teo KK, Yusuf S. Effects of beta blockers, calcium channel blockers, nitrates, and magnesium in acute myocardial infarction and unstable angina pectoris. In: 3rd ed.  Topol EJ editors. Textbook of interventional cardiology. Philadelphia: WB Saunders; 1998;p. 53–66
  7. Groppo Italiano per lo Studio della Soprawivenza nell’Infarto Miocardico . GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after myocardial infarction. Lancet. 1994;343:1115–1122
  8. ISIS-4 Fourth International Study of Infarct Survival collaborative group . ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669–685
  9. European Study of Prevention of Infarct with Molsidomine ESPRIM group . The ESPRIM trial: short-term treatment of acute myocardial infarction with molsidomine. Lancet. 1994;344:91–97
  10. Gobel EJAM, Hautvast R, van Gilst W, Spanjaard JN, Hillege HL, DeJongste MJL, et al.  Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris. Lancet. 1995;346:1653–1657
  11. Conti CR. Use of nitrates in unstable angina. Am J Cardiol. 1987;60:31H–34H
  12. Aronow WS, Chesluk HM. Sublingual isosorbide dinitrate therapy versus sublingual placebo in angina pectoris. Circulation. 1970;41:869–874
  13. Danahy DT, Aronow WS. Hemodynamics and antianginal effects of high dose oral isosorbide ninitrate after chronic use. Circulation. 1977;56:205–212
  14. Markis JE, Gorlin R, Mills RM, Williams RA, Schweitzer P, Ransil BJ. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris. Am J Cardiol. 1979;43:265–271
  15. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, et al.  Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314:1547–1552
  16. Nakamura Y, Moss AJ, Brown MW, Kinohiko M, Kawai C, for the Multicenter Myocardial Ischemia Research Group . Chronic nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale post-infarction studies. Am Heart J. 1999;138:577–585
  17. Moss AJ, Goldstein RE, Hall WJ, Bigger JT, Fleiss JL, Greenberg H, et al.  Detection and significance of myocardial ischemia in stable patients after recoevry from an acute coronary event. JAMA. 1993;269:2379–2385
  18. The Multicenter Diltiazem Postinfarction Trial Research Group . The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 1988;319:385–392
  19. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55
  20. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:663–757
  21. Drake C. Effects of misspecification of the propensity score on estimators of treatment effect. Biometrics. 1993;49:1231–1236

☆ From the EPICORE Centre, Division of Cardiology, University of Alberta, and Department of Biostatistics, University of North Carolina.

☆☆ Reprint requests: Koon K. Teo, MB, PhD, 2C2 WMC, University of Alberta Hospital, Edmonton, Alberta, Canada T6G 2B7.

★ Am Heart J 1999;138:400-2.

★★ 0002-8703/99/$8.00 + 0   4/4/98029

PII: S0002-8703(99)70139-0

American Heart Journal
Volume 138, Issue 3 , Pages 400-402 , September 1999

Article Tools